Related references
Note: Only part of the references are listed.All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
C-SURFER: GRAZOPREVIR PLUS ELBASVIR IN TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION AND CHRONIC KIDNEY DISEASE
D. Roth et al.
JOURNAL OF HEPATOLOGY (2015)
A PHASE 3, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 12 WEEKS OF SIMEPREVIR (SMV) PLUS SOFOSBUVIR (SOF) IN TREATMENT-NAIVE OR -EXPERIENCED PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION AND CIRRHOSIS: OPTIMIST-2
E. Lawitz et al.
JOURNAL OF HEPATOLOGY (2015)
DACLATASVIR, SOFOSBUVIR, AND RIBAVIRIN COMBINATION FOR HCV PATIENTS WITH ADVANCED CIRRHOSIS OR POSTTRANSPLANT RECURRENCE: PHASE 3 ALLY-1 STUDY
F. Poordad et al.
JOURNAL OF HEPATOLOGY (2015)
SAFETY AND EFFICACY OF NOVEL ANTIVIRALS IN KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
M. V. Lin et al.
JOURNAL OF HEPATOLOGY (2015)
SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR PLUS DASABUVIR FOR TREATING HCV GT1 INFECTION IN PATIENTS WITH SEVERE RENAL IMPAIRMENT OR END-STAGE RENAL DISEASE: THE RUBY-I STUDY
P. J. Pockros et al.
JOURNAL OF HEPATOLOGY (2015)
Clinical trial watch: Reports from the AASLD Liver Meeting®, Boston, November 2014
Maria-Carlota Londono et al.
JOURNAL OF HEPATOLOGY (2015)
Treatment of Hepatitis C After Kidney Transplant: A Pooled Analysis of Observational Studies
Fabrizio Fabrizi et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
Eric Lawitz et al.
LANCET (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Interferon-Free Regimens in the Liver-Transplant Setting
Sabela Lens et al.
SEMINARS IN LIVER DISEASE (2014)
Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients
David A. Goodkin et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Hepatitis C treatment in patients with kidney disease
Fabrizio Fabrizi et al.
KIDNEY INTERNATIONAL (2013)
Hepatitis C virus infection in hemodialysis patients
Anais Vallet-Pichard et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Effect of Kidney Transplantation on Outcomes among Patients with Hepatitis C
David Roth et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement
Adrian Covic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Share Paper
